KnowTheStock
Log inCreate free account

THERMO FISHER SCIENTIFIC INC.

TMO
S&P 500Measuring & Controlling Devices, NEC · NYSE
$675.00last close · market cap 250.43 Billion
Compare with…
56.0SCORE / 100
Our verdictSELLModerate Growth and Stable, Stock Price Very HighQtr Ending 2026-09-26

Why Sell

Cash flow is strong; income statement and balance sheet are moderate.

Next earnings: 2026-10-21 (BMO), EPS Forecast: $6.40

What is strong
  • Net Margin is 14.94%
  • Debt Ratio is 0.16
  • Total Debt to Total Assets Ratio is 0.36
  • Cash from Operations Growth is 21.87%
  • Capital Expenditure is Low
  • Net Increase in Cash is Positive
What to watch
  • Revenue Growth is 8.27%
  • Operating Income Growth is 12.8%
  • Net Income Growth is 7.64%
  • Earnings Per Share (EPS) Growth is 9.54%
  • Current Asset to Current Liability Ratio is 1.81
  • Current Debt to Net Income Ratio is 1.31
  • Investment Risk is High

What changed

Score by quarter

Downgraded from Hold to Sell in the Jul 2023 quarter: 60.8 → 58.4 (-2.4). This quarter: +2.7.

506070Apr 2023Sep 2026

What the score is made of

Income statement59.5 +2.6
Balance sheet47.2 +0.1
Cash flow60.0 +7.7

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)47.35 Billion8.27 % growth
EPS18.959.54 % growth
Profit margin14.94 %Profit per $1 of sales
P-E ratio—Not available
Market cap250.43 BillionShares × price
Debt-equity ratio0.76Leverage
Dividend1.84Per share, annual
Next earnings2026-10-21BMO · EPS forecast $6.40
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About THERMO FISHER SCIENTIFIC INC.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. 

CEO
Marc Casper
Employees
130,000
Sector
Manufacturing
Exchange
NYSE
thermofisher.com

Similar stocks

Loading…